Luminus Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-261,200
Closed -$3.53M 20
2025
Q1
$3.53M Sell
261,200
-1,596,500
-86% -$26.5M 1.17% 11
2024
Q4
$31.4M Buy
1,857,700
+1,099,900
+145% +$21.4M 36.27% 1
2024
Q3
$15.4M Buy
757,800
+699,500
+1,200% +$14.3M 7.81% 5
2024
Q2
$1.32M Sell
58,300
-1,424,900
-96% -$37.3M 0.76% 14
2024
Q1
$38.9M Buy
1,483,200
+1,097,900
+285% +$31.3M 17.72% 1
2023
Q4
$12.2M Buy
+385,300
New +$10.5M 3.36% 8
2016
Q1
Sell
-19,800
Closed -$106K 122
2015
Q4
$106K Hold
19,800
﹤0.01% 125
2015
Q3
$128K Buy
+19,800
New +$207K ﹤0.01% 134

Other funds holding CC

Luminus Management's CC Position: Q1 2026 in Review

Luminus Management increased its Chemours (CC) stake by 163% in Q1 2026, buying an estimated $10.1M and bringing the position to 940,552 shares worth $20.7M. The position accounts for 12.52% of the portfolio, ranked #2.

Luminus Management first reported a position in CC in Q1 2016 and has held it in 30 quarters since. The position peaked at $32.8M in Q3 2024. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Luminus Management held 940,552 shares of Chemours worth $20.7M as of Q1 2026.
  • Luminus Management bought 582,483 Chemours shares in Q1 2026, an estimated $10.1M.
  • Chemours made up 12.52% of Luminus Management's portfolio in Q1 2026, its #2 holding.
  • Luminus Management first reported a position in Chemours in Q1 2016 and has held it in 30 quarters since.
  • Luminus Management's Chemours position peaked at $32.8M in Q3 2024.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Luminus Management's 13F filing for Q1 2026, filed 15 May 2026.